Key statistics
On Wednesday, Century Therapeutics Inc (IPSC:NSQ) closed at 1.40, 9.38% above its 52-week low of 1.28, set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.48 |
---|---|
High | 1.49 |
Low | 1.39 |
Bid | 1.39 |
Offer | 1.47 |
Previous close | 1.46 |
Average volume | 395.20k |
---|---|
Shares outstanding | 84.72m |
Free float | 60.64m |
P/E (TTM) | -- |
Market cap | 123.69m USD |
EPS (TTM) | -2.04 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 21:00 BST.
More ▼
Announcements
- Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
- Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
- Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
- Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
- Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
- Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
- Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
- Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
- Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
More ▼